PROK
ProKidney Corp.
1.60$
-8.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +14.0% | -3.8% | +15.2% | +17.0% | +5.9% | +1.7% | -8.4% | -4.6% | +31.4% | -9.7% | +1.2% | – | |
| – | -149.0% | – | +1.7% | -11.2% | +0.2% | -7.7% | +1.9% | +2.1% | -14.6% | -13.3% | +13.1% | – | |
| – | -33.7% | -248.8% | – | – | – | -93.7% | -269.9% | – | -41.9% | -793.9% | – | – | |
| – | -94.4% | -38.9% | -33.8% | +278.0% | +961.1% | -95.6% | +174.2% | +67.0% | +10.7% | -34.2% | +1.3% | – | |
| – | +237.8% | – | -51.1% | -385.7% | – | +87.6% | -34.4% | +56.3% | -3.2% | +24.0% | -63.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +0.0% | -14.3% | +16.7% | – | -200.0% | -40.0% | +66.7% | – | |
| – | +73,069.2% | -99.9% | – | -96.8% | -97.2% | -109.8% | +16.7% | – | +121.5% | -98.8% | +151.6% | – | |
| – | – | – | +448.1% | -181.8% | – | – | – | – | +27.3% | -150.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.